Sg Americas Securities, LLC Wave Life Sciences Ltd. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 36,563 shares of WVE stock, worth $492,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,563
Previous 133,827 72.68%
Holding current value
$492,869
Previous $668,000 55.09%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
SELL
$5.12 - $9.01 $497,991 - $876,348
-97,264 Reduced 72.68%
36,563 $300,000
Q2 2024

Jul 12, 2024
BUY
$4.38 - $6.48 $586,162 - $867,198
133,827 New
133,827 $668,000
Q4 2023

Jan 12, 2024
BUY
$4.16 - $6.87 $36,167 - $59,727
8,694 Added 33.61%
34,562 $175,000
Q3 2023

Oct 13, 2023
BUY
$3.56 - $5.75 $92,090 - $148,741
25,868 New
25,868 $149,000
Q2 2022

Jul 29, 2022
SELL
$1.23 - $3.25 $597,839 - $1.58 Million
-486,048 Closed
0 $0
Q1 2022

Apr 29, 2022
SELL
$2.0 - $3.28 $661,380 - $1.08 Million
-330,690 Reduced 40.49%
486,048 $972,000
Q4 2021

Feb 07, 2022
BUY
$3.14 - $5.15 $2.22 Million - $3.65 Million
707,924 Added 650.58%
816,738 $2.57 Million
Q3 2021

Nov 01, 2021
BUY
$4.89 - $7.12 $532,100 - $774,755
108,814 New
108,814 $533,000
Q3 2020

Nov 09, 2020
SELL
$8.49 - $19.54 $94,553 - $217,616
-11,137 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$7.44 - $11.29 $82,859 - $125,736
11,137 New
11,137 $116,000
Q2 2019

Jul 29, 2019
SELL
$22.93 - $42.84 $82,593 - $154,309
-3,602 Closed
0 $0
Q1 2019

Apr 29, 2019
BUY
$32.69 - $47.91 $117,749 - $172,571
3,602 New
3,602 $140,000

Others Institutions Holding WVE

# of Institutions
164
Shares Held
117M
Call Options Held
148K
Put Options Held
109K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email